Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Sakari Rannikko"'
Autor:
Tolou Shadbahr, Michael Roberts, Jan Stanczuk, Julian Gilbey, Philip Teare, Sören Dittmer, Matthew Thorpe, Ramon Viñas Torné, Evis Sala, Pietro Lió, Mishal Patel, Jacobus Preller, AIX-COVNET Collaboration, James H. F. Rudd, Tuomas Mirtti, Antti Sakari Rannikko, John A. D. Aston, Jing Tang, Carola-Bibiane Schönlieb
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-15 (2023)
Abstract Background Classifying samples in incomplete datasets is a common aim for machine learning practitioners, but is non-trivial. Missing data is found in most real-world datasets and these missing values are typically imputed using established
Externí odkaz:
https://doaj.org/article/9d3ea5d2aba94675b450444e5c79243e
Publikováno v:
The Prostate. 67:447-455
BACKROUND The aim of the study was to evaluate overall and prostate cancer (PCa) specific survival with special attention to cardiovascular (CV) mortality in patients primarily treated by parenteral polyestradiol phosphate (PEP) 240 mg/month or with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31bed619e8ed55bcb731c9dcbe51fadd
https://doi.org/10.1002/pros.20547
https://doi.org/10.1002/pros.20547
Publikováno v:
The Prostate. 66:82-87
BACKGROUND Phytoestrogens have been suggested to reduce the risk of prostate cancer (CaP), but no data exists on how oral phytoestrogen supplementation influences phytoestrogen concentrations in prostate tissue. METHODS Forty men with CaP, assigned f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::020f78de8502e433d7766dd3f5ac0290
https://doi.org/10.1002/pros.20315
https://doi.org/10.1002/pros.20315
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 39:294-300
To evaluate the cardiovascular (CV) complications associated with orchiectomy (OE) and parenteral polyestradiol phosphate (PEP) therapy (240 mg/month), taking into account the effect of pretreatment diseases and pretreatment medication.A total of 244
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe5f8c9cb1f4133901210d50e599a1a
https://doi.org/10.1080/00365590510031228
https://doi.org/10.1080/00365590510031228
Autor:
Teuvo L.J. Tammela, Sakari Rannikko, Patrik Finne, Anssi Auvinen, Ulf-Håkan Stenman, Liisa Määttänen, Harri Juusela, Matti Hakama, Jussi Aro
Publikováno v:
International Journal of Cancer. 111:940-943
We estimated the sensitivity of serum prostate-specific antigen (PSA) as a screening test for prostate cancer in the Finnish randomised, population-based prostate cancer screening trial. The study population consisted of 80,458 men aged 55-67 years i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e37571d2a3f7d4ab15fc31c89163cf4
https://doi.org/10.1002/ijc.20352
https://doi.org/10.1002/ijc.20352
Autor:
Sakari Rannikko, Liisa Määttänen, Patrik Finne, Anssi Auvinen, Ulf-Håkan Stenman, Harri Juusela, Jussi Aro, Matti Hakama, Teuvo L.J. Tammela
Publikováno v:
European Urology. 41:619-627
Background and Objective: Approximately 70% of the men with an elevated serum prostate-specific antigen (PSA) identified in prostate cancer screening do not have prostate cancer. Other available diagnostic variables may be utilized to reduce the numb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac7079194132871f11f8fd3483e1b7c
https://doi.org/10.1016/s0302-2838(02)00179-3
https://doi.org/10.1016/s0302-2838(02)00179-3
Autor:
Sakari Rannikko, Anssi Auvinen, Ulf-Håkan Stenman, Teuvo L.J. Tammela, Liisa Määttänen, Harri Juusela, Jussi Aro, Matti Hakama
Publikováno v:
Cancer Causes and Control. 13:279-285
Objective: Lead-time in prostate cancer screening was estimated using data from the Finnish randomized, population-based trial. Methods: Lead-time was defined as the duration of follow-up needed to accrue the same expected number of incident prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea03d3debf3c16937f35ed249375c5f3
https://doi.org/10.1023/a:1015040231402
https://doi.org/10.1023/a:1015040231402
Publikováno v:
Acta Radiologica. 42:348-354
Purpose: We assessed the accuracy of MR imaging in differentiating between cancer and other prostatic disorders, and evaluated the diagnostic criteria for various prostatic diseases. Material and Methods: A total of 74 endorectal coil MR studies were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea43493d6e977b35000cbb7dfb7a6a6
https://doi.org/10.1080/028418501127346972
https://doi.org/10.1080/028418501127346972
Autor:
Markku Seppälä, Sakari Rannikko, Teuvo L.J. Tammela, Anssi Auvinen, Hannu Koistinen, Matti Hakama, Wan-Ming Zhang, Patrik Finne, Liisa Määttänen, Ulf-Håkan Stenman
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:2744-2747
High serum levels of insulin-like growth factor I (IGF-I) and low levels of IGF-binding protein-3 (IGFBP-3) have been shown to correlate with increased prostate cancer risk. To evaluate this, IGF-I, IGFBP-3, and prostate-specific antigen (PSA) were m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4ea3d72ae944a3bbee6c6e5c2fe8d40
https://doi.org/10.1210/jcem.85.8.6725
https://doi.org/10.1210/jcem.85.8.6725
Autor:
Tapio Vehmas, Pekka Tervahartiala, J. O. Salo, Leena Kivisaari, S. Ikonen, Sakari Rannikko, Kimmo Taari, Päivi Kärkkäinen
Publikováno v:
The Prostate. 43:43-48
Background Both Gleason score and prostate-specific antigen (PSA) concentration are prognostic factors for prostate cancer. We assessed our ability to localize cancer lesions based on Gleason scores and PSA values by endorectal coil magnetic resonanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26acb73f9828de4659273c337a77f7e
https://doi.org/10.1002/(sici)1097-0045(20000401)43:1<43::aid-pros6>3.0.co
https://doi.org/10.1002/(sici)1097-0045(20000401)43:1<43::aid-pros6>3.0.co